CDNA
CareDx, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$67.08
+4.81%0
Insider buys (3m)
5
Insider sells (3m)
-$3.9M
Net value (3m)
+74.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 5, 2026 | Meng Jessica · officer: Chief Commercial Officer | F-InKind | 2,619 | $66 |
| Oct 5, 2026 | Hanna John Walter JR · director, officer: President and CEO | F-InKind | 8,511 | $66 |
| Oct 5, 2026 | Kennedy Keith · officer: CFO & COO | F-InKind | 3,018 | $66 |
| Oct 5, 2026 | Goldberg Michael · director | A-Award | 588 | $0.00 |
| Oct 5, 2026 | Novack Jeffrey Adam · officer: Secretary and General Counsel | F-InKind | 997 | $66 |
| Sep 15, 2026 | Meng Jessica · officer: Chief Commercial Officer | F-InKind | 6,688 | $52 |
| Sep 15, 2026 | Kennedy Keith · officer: CFO & COO | F-InKind | 8,220 | $52 |
| Aug 6, 2026 | Goldberg Michael · director | Sale | 44,700 | $47 |
| Aug 6, 2026 | Novack Jeffrey Adam · officer: Secretary and General Counsel | Sale | 500 | $47 |
| Aug 6, 2026 | Bickerstaff George · director | Sale | 20,000 | $46 |
| Aug 6, 2026 | COURNOYER CHRISTINE · director | Sale | 16,000 | $47 |
| Aug 6, 2026 | Novack Jeffrey Adam · officer: Secretary and General Counsel | Sale | 2,188 | $46 |
| Aug 4, 2026 | Novack Jeffrey Adam · officer: Secretary and General Counsel | F-InKind | 2,872 | $48 |
| Jul 17, 2026 | Hanna John Walter JR · director, officer: President and CEO | Sale | 68,000 | $39 |
| Jul 17, 2026 | Hanna John Walter JR · director, officer: President and CEO | Sale | 50,000 | $36 |
| Jul 17, 2026 | Hanna John Walter JR · director, officer: President and CEO | M-Exempt | 118,000 | $8.20 |
| Jul 17, 2026 | Valantine Hannah · director | M-Exempt | 7,606 | $21 |
| Jul 17, 2026 | Valantine Hannah · director | M-Exempt | 16,048 | $14 |
| Jul 17, 2026 | Valantine Hannah · director | M-Exempt | 5,125 | $7.96 |
| Jul 17, 2026 | Valantine Hannah · director | Sale | 100 | $37 |
| Jul 17, 2026 | Valantine Hannah · director | Sale | 28,679 | $36 |
| Jul 7, 2026 | Goldberg Michael · director | A-Award | 1,746 | $0.00 |
| Jul 6, 2026 | Hanna John Walter JR · director, officer: President and CEO | F-InKind | 8,511 | $29 |
| Jul 2, 2026 | Kennedy Keith · officer: CFO & COO | F-InKind | 2,930 | $29 |
| Jul 2, 2026 | Meng Jessica · officer: Chief Commercial Officer | F-InKind | 2,411 | $29 |
| Jul 2, 2026 | Novack Jeffrey Adam · officer: Secretary and General Counsel | F-InKind | 997 | $29 |
| Jun 30, 2026 | Hanna John Walter JR · director, officer: President and CEO | M-Exempt | 100 | $8.20 |
| Jun 30, 2026 | Hanna John Walter JR · director, officer: President and CEO | M-Exempt | 706 | $8.20 |
| Jun 30, 2026 | Hanna John Walter JR · director, officer: President and CEO | M-Exempt | 15,676 | $8.20 |
| Jun 30, 2026 | Hanna John Walter JR · director, officer: President and CEO | Sale | 100 | $29 |
Institutional positioning
13F filings over the trailing two quarters
New 85Increased 150Reduced 127Sold out 17
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 4,814,709 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 4,522,096 | May 13, 2026 |
| BAMCO INC /NY/ | Increased | 3,336,409 | May 15, 2026 |
| STATE STREET CORP | Increased | 2,760,385 | May 15, 2026 |
| STATE STREET CORP | Reduced | 2,468,858 | Sep 22, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Increased | 2,227,556 | May 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,197,475 | Aug 13, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 2,191,000 | May 15, 2026 |
| BRAIDWELL LP | Increased | 2,173,146 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,160,457 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Reduced | 1,997,618 | Aug 14, 2026 |
| ARK Investment Management LLC | Reduced | 1,953,531 | Aug 14, 2026 |
| Boston Partners | Increased | 1,937,601 | Aug 4, 2026 |
| BAMCO INC /NY/ | Reduced | 1,937,326 | Aug 14, 2026 |
| BOSTON PARTNERS | Increased | 1,883,534 | May 11, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 5, 2026